BRPI0612781B8 - uso de um meio de cultura livre de soro para reduzir os níveis de formas oxidadas de uma gonadotrofina dimérica recombinante durante seu processo de fabricação - Google Patents

uso de um meio de cultura livre de soro para reduzir os níveis de formas oxidadas de uma gonadotrofina dimérica recombinante durante seu processo de fabricação

Info

Publication number
BRPI0612781B8
BRPI0612781B8 BRPI0612781A BRPI0612781A BRPI0612781B8 BR PI0612781 B8 BRPI0612781 B8 BR PI0612781B8 BR PI0612781 A BRPI0612781 A BR PI0612781A BR PI0612781 A BRPI0612781 A BR PI0612781A BR PI0612781 B8 BRPI0612781 B8 BR PI0612781B8
Authority
BR
Brazil
Prior art keywords
serum
culture medium
free culture
manufacturing process
oxidized forms
Prior art date
Application number
BRPI0612781A
Other languages
English (en)
Inventor
Fonta Jean-Pierre
Ducommun Paul
Deparis Véronique
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of BRPI0612781A2 publication Critical patent/BRPI0612781A2/pt
Publication of BRPI0612781B1 publication Critical patent/BRPI0612781B1/pt
Publication of BRPI0612781B8 publication Critical patent/BRPI0612781B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/44—Thiols, e.g. mercaptoethanol
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2511/00—Cells for large scale production

Abstract

meio de cultura livre de soro para a produção de gonadotropinas recombinantes. a presente invenção refere-se à fabricação de proteínas recombinantes. mais especificamente, ela se refere ao uso de um meio de cultura livre de soro compreendendo um antioxidante para a produção de gonadotropinas diméricas recombinantes. o antioxidante pode ser selecionado a partir do grupo consistindo em l-glutationa, 2-mercaptoetanol, l-metionina, e uma combinação de ácido ascórbico e de (+)-alfa-tocoferol.
BRPI0612781A 2005-07-05 2006-07-04 uso de um meio de cultura livre de soro para reduzir os níveis de formas oxidadas de uma gonadotrofina dimérica recombinante durante seu processo de fabricação BRPI0612781B8 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP05106060 2005-07-05
EP05106060.6 2005-07-05
US69707705P 2005-07-06 2005-07-06
US60/697,077 2005-07-06
PCT/EP2006/063862 WO2007003640A1 (en) 2005-07-05 2006-07-04 Serum-free culture medium for the production of recombinant gonadotropins

Publications (3)

Publication Number Publication Date
BRPI0612781A2 BRPI0612781A2 (pt) 2010-11-30
BRPI0612781B1 BRPI0612781B1 (pt) 2020-09-15
BRPI0612781B8 true BRPI0612781B8 (pt) 2021-05-25

Family

ID=35134140

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0612781A BRPI0612781B8 (pt) 2005-07-05 2006-07-04 uso de um meio de cultura livre de soro para reduzir os níveis de formas oxidadas de uma gonadotrofina dimérica recombinante durante seu processo de fabricação

Country Status (24)

Country Link
US (1) US8093052B2 (pt)
EP (1) EP1899454B1 (pt)
JP (1) JP5059757B2 (pt)
KR (1) KR101346499B1 (pt)
CN (1) CN101258236A (pt)
AR (1) AR054157A1 (pt)
AU (1) AU2006264917B2 (pt)
BR (1) BRPI0612781B8 (pt)
CA (1) CA2613867A1 (pt)
CY (1) CY1112992T1 (pt)
DK (1) DK1899454T3 (pt)
EA (1) EA012840B1 (pt)
ES (1) ES2388875T3 (pt)
HR (1) HRP20120486T1 (pt)
IL (1) IL188558A (pt)
MY (1) MY149621A (pt)
NO (1) NO341475B1 (pt)
PL (1) PL1899454T3 (pt)
PT (1) PT1899454E (pt)
RS (1) RS52468B (pt)
SI (1) SI1899454T1 (pt)
TW (1) TWI369401B (pt)
UA (1) UA91063C2 (pt)
WO (1) WO2007003640A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101264096B (zh) * 2007-03-12 2011-11-09 中国医学科学院药物研究所 人参皂苷Rg1在制备生精产品中的应用
PT2170942E (pt) * 2007-06-28 2013-10-22 Biogenerix Ag Clone celular produtor de fsh
AU2011246504B2 (en) 2010-04-26 2013-09-26 Novartis Ag Improved cell culture medium
CN102296047B (zh) * 2011-08-13 2013-03-13 新疆农垦科学院 利用羔羊超排卵母细胞生产体外胚胎的方法
US10138467B2 (en) * 2013-10-14 2018-11-27 Ares Trading S.A. Medium for high performance mammalian fed-batch cultures
EP3383894B1 (en) * 2015-12-02 2020-05-06 CSL Behring Lengnau AG Improved media for the expression of recombinant vitamin k-dependent proteins
CN105462909B (zh) * 2015-12-31 2019-09-27 哈药集团技术中心 一种高效表达人促卵泡激素的cho细胞的培养方法
CN108795841A (zh) * 2017-05-03 2018-11-13 上海奥浦迈生物科技有限公司 一种st培养基及其应用
CN110042137B (zh) * 2019-05-14 2023-02-28 上海赛迈生物科技有限公司 高密度灌注培养重组cho细胞生产人促卵泡激素的方法、培养基及其应用
US20220204920A1 (en) 2019-05-16 2022-06-30 Formycon Ag Method for reducing methionine oxidation in recombinant proteins
CN114836367A (zh) * 2022-04-28 2022-08-02 上海东富龙生物试剂有限公司 用于hek293细胞培养及腺病毒、腺相关病毒复制扩增的化学成分限定培养基

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3110559C2 (de) 1981-03-18 1985-05-09 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Vollsynthetisches Zellkulturmedium
US4560655A (en) * 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) * 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
FR2600076A1 (fr) * 1986-06-12 1987-12-18 Fond Ctre Nal Transfusion Milieu de culture comportant de l'albumine humaine, procede de preparation d'un produit injectable a partir de ce milieu, produit obtenu et son utilisation, composition obtenue
US5122469A (en) * 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
GB9022545D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Culture medium
USH1532H (en) * 1993-11-03 1996-05-07 Genetics Institute, Inc. Adaption of mammalian cell lines to high cell densities
WO1998004680A1 (en) * 1996-07-26 1998-02-05 University Of Manitoba Serum-free medium for growth of anchorage-dependant mammalian cells
EP2221361A3 (en) * 1996-08-30 2011-02-09 Life Technologies Corporation Method for producing a polypeptide in vitro in mammalian cells in a protein-free and serum-free culture medium
DE69738806D1 (de) * 1996-10-10 2008-08-14 Invitrogen Corp Tierzellkulturmedium mit pflanzlichen nährstoffen
IL122732A0 (en) * 1997-01-15 1998-08-16 Akzo Nobel Nv Liquid gonadotropin-containing formulation its preparation and a device containing same
WO1999050390A1 (en) * 1998-03-30 1999-10-07 Bionative Ab Methionin containing animal cell culture medium and its use
CA2468971A1 (en) * 2001-12-04 2003-06-12 Mitsubishi Pharma Corporation Method of activating protein
US6756431B2 (en) * 2002-04-09 2004-06-29 Crompton Corporation Heterocyclic tin flame retardants/smoke suppressants and halogen-containing polymer composition containing same
WO2004087213A1 (en) * 2003-04-02 2004-10-14 Ares Trading S.A. Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant
PT1638595E (pt) * 2003-06-20 2013-04-26 Ares Trading Sa Fsh liofilizada / formulações de hl

Also Published As

Publication number Publication date
AU2006264917A1 (en) 2007-01-11
CN101258236A (zh) 2008-09-03
NO341475B1 (no) 2017-11-27
US8093052B2 (en) 2012-01-10
BRPI0612781A2 (pt) 2010-11-30
ES2388875T3 (es) 2012-10-19
CA2613867A1 (en) 2007-01-11
CY1112992T1 (el) 2016-04-13
BRPI0612781B1 (pt) 2020-09-15
US20090124006A1 (en) 2009-05-14
JP5059757B2 (ja) 2012-10-31
MY149621A (en) 2013-09-13
KR20080036599A (ko) 2008-04-28
PT1899454E (pt) 2012-06-25
KR101346499B1 (ko) 2013-12-31
JP2008544758A (ja) 2008-12-11
DK1899454T3 (da) 2012-07-09
RS52468B (en) 2013-02-28
TWI369401B (en) 2012-08-01
IL188558A0 (en) 2008-04-13
EA200800253A1 (ru) 2008-06-30
EP1899454B1 (en) 2012-05-30
IL188558A (en) 2012-04-30
EA012840B1 (ru) 2009-12-30
AU2006264917B2 (en) 2011-04-28
HRP20120486T1 (hr) 2012-07-31
AR054157A1 (es) 2007-06-06
UA91063C2 (ru) 2010-06-25
NO20080580L (no) 2008-01-31
WO2007003640A1 (en) 2007-01-11
TW200732473A (en) 2007-09-01
EP1899454A1 (en) 2008-03-19
PL1899454T3 (pl) 2012-10-31
SI1899454T1 (sl) 2012-08-31

Similar Documents

Publication Publication Date Title
BRPI0612781B8 (pt) uso de um meio de cultura livre de soro para reduzir os níveis de formas oxidadas de uma gonadotrofina dimérica recombinante durante seu processo de fabricação
BRPI0520498B8 (pt) processo para fabricação de interferon beta humano recombinante glicosilado, e uso de um meio de cultura isento de soro
ATE455752T1 (de) Herstellung von (2r,3r)-3-(3-methoxyphenyl)-n,n,2-trimethylpent namin
ATE477321T1 (de) Aviäre telomerase reverse transkriptase
MX2010006436A (es) Derivados peptidos mimeticos de eritropoyetina y sus sales farmaceuticas, su preparacion y usos.
AR048938A1 (es) Cepas de levadura que producen colesterol y sus aplicaciones
AR070633A1 (es) Metodos para modificar el punto isoelectrico de anticuerpos mediante la sustitucion de aminoacidos en la region de determinacion de la complementariedad (cdr)
EA200870451A1 (ru) Педиатрический аминокислотный раствор для парентерального питания
SV2006002218A (es) Fenilaminotiazoles sustituidos y su uso ref.bhc041280-sv
TN2009000249A1 (en) Mapk/erk kinase inhibitors
AR064327A1 (es) Un metodo para preparar montelukast e intermediarios utilizados en el mismo
HN2005000114A (es) Procedimiento para purificar mesotriona.
BR112015005416A2 (pt) produção de ácidos orgânicos por meio de fermentação em baixo ph
AR065634A1 (es) Metodo para la produccion de acido citrico
ATE530660T1 (de) Enzymatische herstellung von (meth)acrylsäureestern
WO2008112911A3 (en) Attenuated reoviruses for selection of cell populations
EA201270204A1 (ru) Таблетка
BRPI0909695B8 (pt) processo de redução, processo de preparação de compostos e processo de preparação de nebivolol
NO20060183L (no) Papirfremstilling med modifiserte silikasoler som mikropartikler
ATE466003T1 (de) Herstellung von 2-aminothiazol-5- carbonsäurederivaten
BRPI0507353A (pt) métodos de produção de l-treonina e de microrganismo produtor de l-treonina e microrganismo
BR112012018956A2 (pt) processo para produção de uma proteína interferon alfa 5
AR053972A1 (es) Procedimiento para produccion de 2 - cloro-4- nitroimidazol
ATE442055T1 (de) Fischfutter mit sojaprotein
Burāne POLITICAL DOCUMENTS IN CONTEMPORARY ART OF LATVIA

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06H Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette]

Free format text: REF. A RPI NO 2153 DE 10/04/2012. ANULACAO DA EXIGENCIA 6.6 POR TER SIDO INDEVIDA. REQUERENTE NAO APRESENTOU RESPOSTA A EXIGENCIA CONFORME DISPOE A RESOLUCAO 207 DE 24/04/2009, ENTRETANTO, A RESPOSTA CONSTA NO FORMULARIO DE DEPOSITO.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 15/09/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/07/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF